Screener
Xeris Biopharma Holdings, Inc. XERS Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001867096-26-000030
FAQ
- What is Xeris Biopharma Holdings, Inc.'s price / book?
- Xeris Biopharma Holdings, Inc. (XERS) reported price / book of 76.9× in Q1 2026.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s price / book?
- Over 3 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s price / book has grown at a 73.6% compound annual growth rate (CAGR), from 18.2× to 95.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Xeris Biopharma Holdings, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude